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ABSTRACT 
 
The crude extracts and the methanol and hexane partitioned fractions from the rhizomes of six Zingiberaceae 
comprising five Curcumas and one Zingiber were screened for dengue-2 (Den2) virus NS2B/NS3 protease 
inhibition. The percentage inhibition of Den2 virus NS2B/NS3 protease cleavage of the substrate showed linear 
dose-dependent increment for all the samples tested. The crude extracts were less potent than the best of the 
partitioned fractions. For all three concentrations studied, the methanol fractions of the extracts of Curcuma 
longa (L.) (CL), Zingiber zerumbet Smith (ZZ) and Curcuma rubescen Roxb. (CR) were much more inhibiting 
than the corresponding hexane fractions but the converse was true for Curcuma aeroginosa Roxb. (CA). 
However, the inhibiting activities of the two partitioned fractions of the extracts of Curcuma mangga Roxb. 
(CM) and Curcuma xanthorhiza Roxb. (CX) were found to be similar. The CL methanol fraction exhibited the 
strongest inhibitory activity (91.3±3.1%, 300 ppm), followed closely by methanol fraction of ZZ (89.0±1.7%, 
300 ppm). The results show that the methanol fractions of CL and ZZ, and both the methanol and hexane 
fractions of CM were most potent against Den2 virus NS2B/NS3 protease activity and may provide potential 
leads towards the development of anti-viral agents. 
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INTRODUCTION 
 
Dengue fever (DF) and dengue haemorrhagic fever (DHF)/dengue shock syndrome (DSS) 
are caused by viruses of the family Flaviviridae. Yellow fever, Japanese encephalitis and 
hepatitis viruses are also members of the Flaviviridae virus family. There are four closely 
related but antigenically distinct dengue virus serotypes (Den1, Den2, Den3, and Den4). All 
four serotypes can possibly cause DF, DHF and DSS. A mosquito-borne disease, dengue is 
characterized by excruciating pain and is also known as “bone-break disease” (Deem, 2006).  
Typical of the Flaviviridae, dengue virus consists of a single positive-sense 1-kilobase 
RNA genome that encodes for a single polyprotein comprising three structural (C, prM, E) 
and seven non-structural (NS) proteins, of sequential order C-prM-E-NS1-NS2A-NS2B-
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NS3-NS4A-NS4B-NS5 (Chambers et al., 1990). The polyprotein precursor is cleaved by 
both host proteases and virus protease complex NS2B/NS3. The viral protease NS3 is highly 
conserved and multi-functional (Wengler et al., 1991; Li et al., 1999), catalyzing the 
polyprotein at several sites (Falgout et al., 1991). Together with its cofactor NS2B, NS3 
catalyzes the cis cleavage of NS2A/NS2B and NS2B/NS3 (Arias et al., 1993; Jan et al., 
1995), and trans cleavage of NS3/NS4A and NS4B/NS5 junctions of the polyprotein 
(Chambers et al., 1990; Preugschat et al., 1990; Zhang et al., 1992; Clum et al., 1997; Valle 
et al., 1998). Furthermore, NS3 and NS5 proteins are thought to be components of the 
putative viral replicase complex (Kapoor et al., 1995; Cui et al., 1998) since NS3 has been 
shown to be regulated by viral RNA polymerase and binds with NS5 both in vitro and in 
vivo. This characteristic, together with the fact that NS3 mediates for a variety of diverse 
functions, has made it a good target for therapeutic intervention of DF/DHF.  
To date, there is neither known cure nor approved vaccine for dengue although 
vaccination is available for yellow fever, tick-borne encephalitis and Japanese encephalitis. 
The current WHO control strategy emphasizes predominantly on vector control, 
surveillance and preparedness. The complexity of the antibody-dependent enhancement and 
original antigen sin (McMichael, 1998) makes development and efficacy of vaccine 
challenging. Previous exposure to one of the four serotypes, either by prior infection or by 
vaccination, makes people much more likely to develop the potentially lethal DHF/DSS if 
they are infected later by one of the other three serotypes. Mongkolsapaya et al. (2003) 
reported recovering few dengue-responsive CD8+ T cells during acute infection and most 
present were undergoing programmed cell death. In the same report, Mongkolsapaya et al. 
(2003) also found that many dengue-specific T cells were of low affinity for the infecting 
virus and showed higher affinity for other, probably previously encountered strains. Patients 
who were given a tetravalent-serotype vaccine wound up only being protected against one 
or two serotypes at most (Deem, 2006).  
There is a need to develop anti-viral agents, both as prophylactic and treatment. A 
therapy similar to the ‘triple combination therapy’ using anti-retroviral drugs for HIV/AIDS 
can be developed eventually for DF/DHF if research is intensified. The typical HIV/AIDS 
triple combination therapy consists of two reverse transcriptase inhibitors and a protease 
inhibitor. A preliminary study of Ritonavir, an inhibitor of HIV-1 protease, has shown that 
the viral loads can be reduced by 99% (Markowitz et al., 1995).  
The Zingiberaceae consists of about 1200 species of which 1000 are found in tropical 
Asia (Larsen et al., 1999). Zingiberaceae rhizomes are widely used in Asia as both 
traditional medicine and spices. The extracts of 13 Zingiberaceae species (Alpinia, Costus 
and Zingiber) were shown to exhibit antibacterial and antioxidant activity (Habsah et al., 
2000). A compound, zerumbone, isolated from Zingiber zerumbet Smith exhibited HIV-
inhibitory and cytotoxic activities (Dai et al., 1997). In addition, zerumbone has also been 
reported to suppress cancer-cell proliferation (Hoffman et al., 2002). The cyclohexenyl 
chalcone derivatives of a Zingiberaceae species, Boesenbergia rotunda (L.) Mansf., are 
reported to be anti-inflammatory (Tuchinda et al., 2002; Yun et al., 2003), strongly anti-
mutagenic (Trakoontivakorn et al., 2001) and Den2 virus protease inhibiting (Tan et al., 
2006). Further, curcumin from tumeric (Curcuma longa L.) has been widely studied and 
reported to exhibit anti-bacterial (Bhavanishankar and Murthy, 1985), anti-inflammatory 
(Rao et al., 1982) and hypocholesteremic effect (Rao et al., 1970; Patil and Srinivasan, 
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1971). In this paper, we describe the Den2 virus NS2B/NS3 protease inhibitory properties of 
six selected Zingiberaceae species comprising five Curcumas and one Zingiber. 
 
 
MATERIALS AND METHODS 
 
Expression and Purification of Den2 Virus NS2B/NS3 Protease  
 
The expression and purification of Den2 virus NS2B/NS3 protease are as reported by Tan et 
al. (2006). The protein precursor consisting of N-terminal hexahistidine tag fused 
sequentially to 40-residue NS2B cofactor, a linker of 10 residues and the first 185 amino 
acids of NS3 was expressed using transformed competent Escherichia coli strain XL1-Blue 
MRF; then harvested, purified and refolded following established procedures to yield 
proteolytically active protease complex, Den2 virus NS2B/NS3 protease (Murthy et al., 
1999; Yusof et al., 2000). Large quantity of competent Escherichia coli strain XL1-Blue 
MRF was cultured in Luria-Bertani broth (LB) medium in the presence of ampicillin 
(100µg/ml) at 37oC. Isopropyl-β-D-thiogalactoside (IPTG) was used to induce protease 
expression. The Den2 virus NS2B/NS3 protease was isolated using Ni2+ -nitrilotriacetic acid 
(NTA)-agarose resin affinity column (Qiagen, Chadowrth, CA) and subsequently purified 
using Sephadex G-75 gel filtration column (Amersham, Pharmacia Biotech, Piscataway, 
NJ). The ammonium sulfate precipitated proteins were then refolded by successive dialysis 
to yield the active Den2 virus NS2B/NS3 protease which was then stored at -70oC until 
used. A 12% SDS-polyacrylamide gel electrophoresis (PAGE) was used to track the 
protease-containing fractions both after Ni2+-NTA and Sephadex G-75 gel filtration, and the 
purity of the enzyme determined after renaturing by dialysis. Protein concentration was 
determined by the Bradford method using a Shimadzu UV-160 A spectrophotometer 
(Shimadzu Corp., Japan).  
 
 
Extraction 
 
All rhizomes, purchased from a local traditional herb supplier, were thoroughly flushed and 
rinsed in multiple changes of water. The rhizomes were sliced thinly and air-dried until 
constant mass. The dried slices were pulverized using a blender and the powder was soaked 
in methanol for several days. The methanol extract obtained after filtration was evaporated 
at 35oC and the resultant slurry liquid was partitioned with equal volume of ethyl acetate and 
water. The ethyl acetate layer was evaporated. The resultant thick brown liquid was further 
partitioned with equal volume of methanol and hexane and the solvents were then 
evaporated. The crude extract and methanol fractions were bio-assayed in methanol, and the 
hexane fractions in hexane.  
 
 
Den2 Virus NS2B/NS3 Protease Inhibition Bioassay using Fluorogenic Peptides  
 
NS2B/NS3 inhibition bioassay protocol was as reported by Tan et al. (2006). The standard 
100 µL reaction mixtures comprised 100 µM fluorogenic peptide substrate Boc-Gly-Arg-
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Arg-MCA (Peptide Institute, Inc., Osaka, Japan), 2 µM Den2 NS2B/NS3 protease, and with 
or without Zingiberaceae extract of varying concentrations buffered at pH 8.5 by 200 mM 
Tris-HCl. Every sample of extract was assayed at three different concentrations; 100, 200 
and 300 ppm. Each test was done in quadruplicate. After enzyme addition, the reaction 
mixtures were incubated for 30 min at 37oC. The reaction was terminated with 1.9 mL of 
125 mM ZnSO4 (Brenner et al., 1992). The resultant precipitate was removed by micro-
centrifugation for 3 min at 13,000 rpm and the supernatant was fluorometrically determined 
for the cleaved product (7-amino-4-methyl-coumarin) concentration at excitation λ = 385 
nm and emission λ = 465 nm using a Shimadzu spectrofluorometer (model RF-5301PC; 
Shimadzu Corp., Japan). Four readings were taken each at time interval of 5 s per test and 
the three most consistent readings (percentage standard deviation <5 %) were accepted.  
 
 
RESULTS AND DISCUSSION 
 
Den2 Virus NS2B/NS3 Protease Inhibitory Properties of Zingiberaceae Extracts 
 
The percentage inhibition of Den2 virus NS2B/NS3 protease cleavage of the substrate 
showed linear dose-dependent increment for all the samples tested (Table I). A 2-way 
ANOVA with Tukey test as the post hoc test showed interaction between concentration and 
extract type. Consequently, a 1-way ANOVA with Tukey test as the post hoc test was 
carried out to check significance of inhibition between different extracts of each species at a 
given concentration. The test showed that all mean percentage inhibition of the crude and 
fractions for a given extract concentration of each species differed at 5% level of 
probability. The mean percentage inhibition of the crude and the fractions were significantly 
different at each extract concentration for each species. It suggests that the combined 
activity of the more polar compounds in methanol was significantly different from those of 
the less polar compounds in hexane. Similarly, the mean percentage inhibition of the crude 
extract differed significantly from those of the two partitioned fractions at all three 
concentrations for each species.  
Generally, the crude extracts were less inhibiting than the best of the partitioned 
fractions. For all three concentrations studied, the methanol fractions of Curcuma longa 
(L.)(CL), Zingiber zerumbet Smith (ZZ) and Curcuma rubescen Roxb (CR) were 
consistently more inhibiting than the corresponding hexane fractions. However, the hexane 
fraction (79.4±3.4%, 300 ppm) of Curcuma aeroginosa Roxb.(CA) was more inhibiting 
than its methanol fraction (44.8±2.4%, 300 ppm) while the inhibiting activities of the two 
partitioned fractions of Curcuma mangga Roxb.(CM) and Curcuma xanthorhiza Roxb.(CX) 
were found to be similar. The CL methanol fraction at 300 ppm exhibited the strongest 
inhibitory activity of 91.3±3.1% whereas its hexane fraction was only weakly inhibiting 
(18.3±1.4%). ZZ methanol fraction negated 89.0±1.7 % (300 ppm) but its hexane fraction 
negated only 46.6±3.1% (300 ppm) of the Den2 virus protease activity. The difference in 
the inhibitory activities of the methanol fraction over the hexane fraction was less 
contrasting  in the case  of CR, nevertheless  its methanol  fraction was twice as inhibiting as 
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Table 1. Inhibition of Dengue-2 Virus Protease NS3 Cleavage of Fluorogenic Peptide 
Substrate Boc-Gly-Arg-Arg-MCA 
Mean Percentage Inhibition ± S.D. (Standard Deviation)  Extract 
CA CL CM CR CX ZZ 
Crude extract/ppm 
100 
200 
300 
 
 
34.9±1.4 
42.2±1.7 
55.1±2.8 
 
49.6±0.7 
53.7±2.8 
70.3±2.1 
 
47.4±1.7 
51.9±1.4 
65.3±4.2 
 
19.7±1.0 
31.7±0.7 
44.2±1.7 
 
39.5±2.1 
45.8±2.4 
57.7±1.4 
 
48.9±1.4 
56.0±4.2 
69.3±2.4 
Methanol fraction/ppm 
100 
200 
300 
 
 
26.4±0.7 
35.8±0.3 
44.8±2.4 
 
57.8±2.4 
71.4±3.8 
91.3±3.1 
 
54.5±2.1 
68.3±3.1 
84.3±1.7 
 
39.1±2.4 
52.4±1.4 
67.8±1.0 
 
38.2±1.0 
59.5±0.3 
73.3±3.8 
 
45.7±2.1 
64.1±0.7 
89.0±1.7 
Hexane fraction/ppm 
100 
200 
300 
 
 
43.5±2.1 
61.9±1.7 
79.4±3.4 
 
9.4±1.0 
14.0±1.7 
18.3±1.4 
 
44.6±0.3 
58.7±0.3 
87.6±2.8 
 
18.6±1.7 
27.3±0.3 
33.4±2.1 
 
33.9±0.7 
51.6±2.1 
72.4±3.1 
 
15.8±0.7 
35.8±3.8 
46.6±3.1 
For each given extract concentration of a species, all the mean values between extract and different fractions 
differed at 5% level of probability by Tukey test. 
CA: Curcuma aeroginosa Roxb.; CL: Curcuma longa L.; CM: Curcuma mangga Val.; 
CR: Curcuma rubescen Roxb.; CX: Curcuma xanthorhiza Roxb.; ZZ: Zingiber zerumbet Smith. 
 
 
hexane fraction (67.8 ±1.0 % and 30.3±2.1 % respectively, 300 ppm). The methanol and 
hexane fractions of CM had comparable inhibition of 84.3±1.7% and 87.6±2.8% 
respectively at 300 ppm. Both partition fractions of CX extract were similarly inhibiting but 
not as potent as those of CL, ZZ, CA and CM. The CR hexane fraction was weakly 
inhibiting unlike its methanol fraction (67.8±1.0%, 300 ppm). 
The results show that the methanol fraction of CL and ZZ, and both methanol and 
hexane fractions of CM were most potent against Den2 virus NS2B/NS3 protease. These 
results suggest that the active compounds of CL and ZZ were probably adequately polar in 
character to be partitioned into methanol. However, the active compounds of CA were 
possibly more lipophilic in character. The CM extract probably had at least two different 
active compounds of considerable different polarity since both its hexane and methanol 
fractions were of comparable activities. Further activity-guided isolation and purification of 
the most active fraction of CL, ZZ, CA and CM followed by spectroscopic analysis are 
needed to establish the nature of the active compounds in these fractions.  
However, the best of the inhibitory activities of these partitioned fractions were lower 
than those reported for pure Zingiberaceae compounds such as the anti-HIV-1 protease 
activity of cardamonin (Tewtrakul et al., 2003) and the Den2 virus NS2B/NS3 protease 
inhibition by the cyclohexenyl chalcone derivatives (Tan et al., 2006). Both sets of 
compounds were extracted from a Zingiberaceae species, Boesenbergia rotunda (L.). 
Nevertheless, it is reasonable to suggest that the purified compounds of these fractions will 
show much higher inhibitory activities towards Den2 virus NS2B/NS3 protease since the 
activities were already good even for extract partitioned fractions. When isolated and 
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identified, the structures of the compounds in the methanol fractions of CL, ZZ and CM and 
the hexane fractions of CM and CA may provide insights to the mechanism of inhibition, 
and possibly lead to the development of effective anti-viral agents.  
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